MariTide is a monthly injection that investors hope could compete against existing weight loss drugs from Novo Nordisk and Eli Lilly.
Related Posts
AI chipmaker Cerebras announces CFIUS clearance, a key step toward IPO
The government decision helps clear the path for an initial public offering from one of Nvidia’s challengers in artificial intelligence chips.
Norway urged to scrap ban on $1.8 trillion wealth fund investing in weapons makers
The debate over how Norway’s wealth fund should respond to the security landscape comes at a time of higher defense spending and soaring industry profits.
PlayStation Network experiences massive outage, frustrating gamers nationwide
In a post on X just before 9 p.m. Friday, Ask PlayStation posted: “We are aware some users might be currently experiencing issues with PSN.”